Bicara Therapeutics

Healthcare

13 September, 2024

Biocon-backed Bicara Therapeutics raises $315 mn in US IPO

Bicara Therapeutics raised $315 million in its initial public offering in the United States, the TPG-backed cancer therapy developer said ......

Premium

Healthcare

07 March, 2023

Biocon spinout Bicara Therapeutics snags $108 mn in Series B round

Bicara Therapeutics, a biotech firm floated by Kiran Mazumdar’s niece Claire Mazumdar, has secured $108 million in a Series B ......